This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


4rqp

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4rqp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rqp OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4rqp RCSB], [http://www.ebi.ac.uk/pdbsum/4rqp PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4rqp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4rqp OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4rqp RCSB], [http://www.ebi.ac.uk/pdbsum/4rqp PDBsum]</span></td></tr>
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able to elicit protective responses against multiple HFMD causative agents. Previously, we have demonstrated that a thermostable recombinant EV71 vaccine candidate can be produced by the insertion of a foreign peptide into the BC loop of VP1 without affecting viral replication. Here we present crystal structures of two different naturally occurring empty particles, one from a clinical C4 strain EV71 and the other from its recombinant virus containing an insertion in the VP1 BC loop. Crystal structure analysis demonstrated that the inserted foreign peptide is well exposed on the particle surface without significant structural changes in the capsid. Importantly, such insertions do not seem to affect the virus uncoating process as illustrated by the conformational similarity between an uncoating intermediate of another recombinant virus and that of EV71. Especially, at least 18 residues from the N terminus of VP1 are transiently externalized. Altogether, our study provides insights into vaccine development against HFMD.
 +
 +
Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design.,Lyu K, Wang GC, He YL, Han JF, Ye Q, Qin CF, Chen R J Biol Chem. 2015 Feb 6;290(6):3198-208. doi: 10.1074/jbc.M114.624536. Epub 2014 , Dec 9. PMID:25492868<ref>PMID:25492868</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>

Revision as of 06:27, 15 April 2015

Crystal structure of the natually occurring empty particle of a clinical C4 strain EV71

4rqp, resolution 3.15Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools